Amphastar Pharmaceuticals, Inc. (AMPH)

NASDAQ: AMPH · USD

$26.3

+0.73 (+2.9%)· Recorded snapshot

Market cap	1.1B
Revenue (ttm)	730M
Net income (ttm)	78.5M
EPS (ttm)	$1.69
Shares out	42.5M
P/E (trailing)	15.6x
P/E (forward)	8.3x
Volume	320,905
Beta	0.90

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 730M
Net income (ttm): 78.5M
EPS (ttm): $1.69
P/E (trailing): 15.6x
P/E (forward): 8.3x
Market cap: 1.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E8.3

P25 n/aP50 n/aP75 n/a

Trailing P/E15.6

P25 n/aP50 n/aP75 n/a

ROE10.3

P25 n/aP50 n/aP75 n/a

ROIC9.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AMPH indicators

Market & fundamental data

Available fields

267

Groups with data

Currency

USD

Showing 267 of 267 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001297184
Company name	Amphastar Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	03209R103
Earnings date	2026-11-09
Earnings time	amc
Employees	1,976
Employees change	-52
Employees growth	-2.56%
Enterprise value	$1.5B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1996
In index	RUSSELL2000
Industry	Drug Manufacturers - Specialty & Generic
IPO date	2014-06-25
Is primary listing	Yes
Is SPAC	No
ISIN number	US03209R1032
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.1B
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$26.30
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	AMPH
U.S. state	California
Website	https://www.amphastar.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	8.8x
Average P/E ratio (10Y)	276.7x
Average P/E ratio (3Y)	12.81x
Average P/E ratio (5Y)	15.8x
Earnings yield	6.41%
EV/Earnings	19.16x
EV/EBIT	10.95x
EV/EBITDA	7.74x
EV/FCF	9.84x
EV/Sales	2.06x
FCF / EV yield	10.16%
FCF yield	13.81%
Forward EV/Sales	1.94x
Forward P/E	8.31x
Forward P/S	1.43x
Graham number	26.18231
Graham upside	0.62%
Industry forward P/E	13.86x
Industry P/E	173.47x
Lynch fair value	$42.17
Lynch upside	62.08%
P/(FCF - SBC) ratio	8.92x
P/(OCF - SBC) ratio	7.11x
P/B ratio	1.42x
P/E ratio	15.59x
P/FCF ratio	7.24x
P/OCF ratio	6x
P/S ratio	1.52x
Price / tangible book value	9.2x
Price/EBITDA ratio	5.69x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	18.82%
EBITDA margin	26.65%
Effective tax rate	23.01%
FCF margin	20.94%
Gross margin	47.68%
Operating margin	18.82%
Pretax margin	13.98%
Profit margin	10.76%
Profit per employee	$39,751
Profitable quarters	22
Profitable years	7
Revenue per employee	$369,443
ROA	5.11%
ROA (5Y)	8.4%
ROCE	9.28%
ROE	10.3%
ROE (5Y)	18.53%
ROIC	9.06%
ROIC (5Y)	16.37%
SBC / revenue	3.95%
Tax / revenue	3.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-37.04%
EPS growth (Q)	4.69%
EPS growth (QoQ)	378.57%
EPS growth 10Y	18.52%
EPS growth 3Y	-4.56%
EPS growth 5Y	51.56%
EPS growth quarters	1
EPS growth years	0
FCF growth	36.28%
FCF growth (Q)	70.75%
FCF growth (QoQ)	11.48%
FCF growth 3Y	15.03%
FCF growth 5Y	23.9%
Gross profit growth	-3.39%
Gross profit growth (Q)	8.07%
Gross profit growth 3Y	8.01%
Gross profit growth 5Y	16.01%
Net income growth	-41.69%
Net income growth (Q)	-2.2%
Net income growth (QoQ)	372.71%
Net income growth 3Y	-8.32%
Net income growth 5Y	49.68%
Net income growth years	0
OCF growth	15.63%
OCF growth (Q)	44.2%
OCF growth (QoQ)	7.28%
OCF growth 10Y	19.89%
OCF growth 3Y	12.14%
OCF growth 5Y	18%
Operating income growth	-24.38%
Operating income growth (Q)	-5.82%
Operating income growth 3Y	1.5%
Operating income growth 5Y	35.97%
Revenue growth	1.02%
Revenue growth (Q)	5.44%
Revenue growth (QoQ)	7.44%
Revenue growth 10Y	10.53%
Revenue growth 3Y	10.51%
Revenue growth 5Y	13.71%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-31.7M
Depreciation and amortization	$57.1M
EBIT	$137.4M
EBITDA	$194.5M
EPS	$1.69
FCF per share	$3.59
Financing cash flow	$-96.5M
Free cash flow	$152.9M
Free cash flow minus SBC	$124M
Gross profit	$348.1M
Income taxes	$23.5M
Investing cash flow	$-52.1M
Net borrowing	$-257,000
Net cash flow	$35.9M
Net income	$78.5M
Operating cash flow minus SBC	$155.7M
Operating income	$137.4M
Revenue	$730M
Stock-based compensation	$28.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.18
Book value per share	$18.06
Debt / EBITDA	3.33
Debt / equity	0.9
Debt / FCF	4.5
Goodwill	$3.3M
Interest coverage	6.32
Long-term assets	$1.1B
Long-term liabilities	$712.4M
Net cash (debt)	$-398.2M
Net cash / market cap	-35.98%
Net debt / EBITDA	2.05
Net debt / equity	0.52
Net debt / FCF	2.6
Piotroski F-Score	4
Property, plant and equipment	$389.1M
Shareholders' equity	$768.2M
Tangible book value	$120.3M
Tangible book value per share	$2.83
Total assets	$1.7B
Total cash	$290.1M
Total debt	$688.3M
Total liabilities	$975.6M
WACC	6.6%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.43
Current assets	$631M
Current liabilities	$263.2M
Current ratio	2.4
Inventory turnover	2.06
Net working capital	$88.9M
Quick ratio	1.66
Working capital	$367.7M
Working capital turnover	1.89

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	7.79%
Dividend yield	0%
Shareholder yield	7.79%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	41.41%
10Y return CAGR	3.53%
10Y total return	41.41%
150-day SMA	$21.53
1D price change	2.85%
1M price change	-0.42%
1M total return	-0.42%
1W price change	0.31%
1W total return	0.31%
1Y price change	8.24%
1Y return CAGR	8.24%
1Y total return	8.24%
20-day SMA	$25.89
200-day SMA	$22.26
3M price change	35.66%
3M total return	35.66%
3Y price change	-41.71%
3Y return CAGR	-16.46%
3Y total return	-41.71%
50-day SMA	$24.53
50-day SMA vs 200-day SMA	50over200
52-week high	$29.52
52-week high date	2026-01-12
52-week low	$16.65
52-week low date	2026-05-18
5Y price change	41.72%
5Y return CAGR	7.22%
5Y total return	41.72%
6M price change	20.19%
6M total return	20.19%
All-time high	$67.66
All-time high date	2023-08-09
All-time low	$8.32
All-time low date	2014-07-02
Average true range (ATR)	$0.84
Average volume	384.1K
Beta (1Y)	0.73
Beta (2Y)	0.66
Beta (5Y)	0.9
Change from 52-week high	-10.91%
Change from 52-week low	58.01%
Change from all-time high	-61.54%
Change from all-time low	212.74%
Change from open	2.53%
Day's gap	0.31%
Dollar volume	$8.4M
High price	$26.35
Low price	$25.65
Monthly RSI	47.79
Open price	$25.65
Position in 52-week range	92.86%
Previous close	$25.57
Price vs 150-day SMA	20.87%
Price vs 20-day SMA	0.51%
Price vs 200-day SMA	16.91%
Price vs 50-day SMA	6.06%
Relative volume	0.84
RSI	55.44
Sharpe ratio	0.35
Sharpe ratio (3Y)	-0.26
Sharpe ratio (5Y)	0.27
Sortino ratio	0.54
Sortino ratio (3Y)	-0.23
Sortino ratio (5Y)	0.5
Volume	320.9K
Weekly RSI	59.88
YTD price change	-2.84%
YTD total return	-2.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	31.3M
Float percentage	73.56%
Shares change (QoQ)	-4.81%
Shares change (YoY)	-7.79%
Shares held by insiders	10.36%
Shares held by institutions	68%
Shares outstanding	42.5M
Short % of float	13.85%
Short % of shares	10.19%
Short ratio	8.2 days

Deeper analysis on AMPH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AMPH report

Is a complete AMPH research report available?

No complete published report is available for Amphastar Pharmaceuticals, Inc. (AMPH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Amphastar Pharmaceuticals, Inc. (AMPH)

Price

Financial snapshot

Fair-value bridge

Latest news · AMPH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AMPH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AMPH

Frequently asked questions